Scholarlink

Background <p>Mouse C2C12 myoblast cell line is widely used as a good in vitro model to study muscle physiology, metabolism, and regeneration. The in vitro model is capable of replicating the main steps of skeletal muscle development, which may help in investigating the molecular mechanism behind myogenesis, muscle degeneration, especially in cancer patients, and in the atrophy of muscles in older people.</p> Objective <p>Considering the in vitro muscle differentiation study, there is a need to develop an ideal protocol for C2C12 myoblast differentiation.</p> Results <p>C2C12 myoblasts were differentiated into myotubes within 4&#xa0;days when cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 2% horse serum, which represents the key feature of myogenesis. Before differentiation, C2C12 cells were cultured up to 90–100% confluence, then the medium was replaced with differentiation media. Then, the cells started to differentiate, on day 2 (D2); the cells were fused with neighboring cells to form long cells. On day&#xa0;3, the cells became more elongated, and on day&#xa0;4, myotubes were clearly detected, having a cylindrical and elongated shape. The cells can be maintained at this stage for more than a week with regular media changes.</p> Conclusion <p>This protocol could be helpful for translational research related to cancer, genetic disorders, and age-related muscle-wasting diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Protocol for in vitro differentiation of C2C12 myoblasts into mature myotubes

  • 期刊论文

  • 发表日期：

    2025年12月27日

查看全文
  • Jong Min Oh,
  • Ji Hyo Lyu,
  • Maic Audo Eybi Mayer Sihombing,
  • Chang-Hwan Bae,
  • Ung Cheol Shin,
  • Subramanian Muthamil,
  • Seon-Wook Kim,
  • M. N. AZIM,
  • Jong-Hoon Kim,
  • Jun Hong Park

摘要

Background

Mouse C2C12 myoblast cell line is widely used as a good in vitro model to study muscle physiology, metabolism, and regeneration. The in vitro model is capable of replicating the main steps of skeletal muscle development, which may help in investigating the molecular mechanism behind myogenesis, muscle degeneration, especially in cancer patients, and in the atrophy of muscles in older people.

Objective

Considering the in vitro muscle differentiation study, there is a need to develop an ideal protocol for C2C12 myoblast differentiation.

Results

C2C12 myoblasts were differentiated into myotubes within 4 days when cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 2% horse serum, which represents the key feature of myogenesis. Before differentiation, C2C12 cells were cultured up to 90–100% confluence, then the medium was replaced with differentiation media. Then, the cells started to differentiate, on day 2 (D2); the cells were fused with neighboring cells to form long cells. On day 3, the cells became more elongated, and on day 4, myotubes were clearly detected, having a cylindrical and elongated shape. The cells can be maintained at this stage for more than a week with regular media changes.

Conclusion

This protocol could be helpful for translational research related to cancer, genetic disorders, and age-related muscle-wasting diseases.